Long-term Outcomes for the Treatment of Paragangliomas in the Upfront, Adjuvant, and Salvage Settings With Stereotactic Radiosurgery and Intensity-modulated Radiotherapy.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 4 12 2019
medline: 10 9 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

To analyze local control (LC) and toxicity rates between stereotactic radiosurgery (SRS) and intensity-modulated radiotherapy (IMRT) in relation to reported surgical rates in the treatment of paragangliomas (PG) in the upfront, adjuvant, and salvage settings, and to explore factors affecting tumor size reduction, toxicity rates, and symptom control. Retrospective cohort analysis. Tertiary referral center. Thirty patients treated with either linear accelerator-based SRS or IMRT in the definitive, planned adjuvant, or unplanned salvage postsurgery settings. Local control, toxicities, symptom control, tumor size reduction, and factors affecting each. Median follow-up was 4.16 years. LC rates were 100%. Acute grade >3 toxicity rate was 6.7%, 86.7% of tumors had a reduction in volume, and 76.7% of patients had improvement in at least one tumor-induced symptom by last follow-up. Larger tumor size at presentation and longer time to last follow-up were significantly associated with greater tumor size reduction on multivariate analysis. SRS and IMRT are safe and effective treatment for PG with high efficacy and low morbidity rates in the upfront, planned adjuvant, and unplanned salvage settings.

Identifiants

pubmed: 31789966
doi: 10.1097/MAO.0000000000002461
pii: 00129492-202001000-00036
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-140

Références

Netterville JL, Sweeney AD, Wanna GB, Deep NL, Carlson ML. The Natural History of Jugular Paraganglioma. In: Contemporary Management of Jugular Paraganglioma; 2017.
Al-Mefty O, Teixeira A. Complex tumors of the glomus jugulare: Criteria, treatment, and outcome. J Neurosurg 2002; 97:1356–1366.
Forbes JA, Brock AA, Ghiassi M, Thompson RC, Haynes DS, Tsai BS. Jugulotympanic paragangliomas: 75 years of evolution in understanding. Neurosurg Focus 2012; 33: E13.
Gilbo P, Morris CG, Amdur RJ, et al. Radiotherapy for benign head and neck paragangliomas: A 45-year experience. Cancer 2014; 120:3738–3743.
Jansen JC, Van Den Berg R, Kuiper A, Van Der Mey AGL, Zwinderman AH, Cornelisse CJ. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 2000; 88:2811–2816.
Langerman A, Athavale SM, Rangarajan SV, Sinard RJ, Netterville JL. Natural history of cervical paragangliomas: Outcomes of observation of 43 patients. Arch Otolaryngol Head Neck Surg 2012; 138:341–345.
Glasscock ME, Jackson CG, Section I. The history of glomus tumors: A personal perspective. Laryngoscope 1993; 103:3–6.
Foote RL, Coffey RJ, Gorman DA, et al. Stereotactic radiosurgery for glomus jugulare tumors: A preliminary report. Int J Radiat Oncol Biol Phys 1997; 38:491–495.
Schuster D, Sweeney AD, Stavas MJ, et al. Initial radiographic tumor control is similar following single or multi-fractionated stereotactic radiosurgery for jugular paragangliomas. Am J Otolaryngol Head Neck Med Surg 2016; 37:255–258.
Lim M, Gibbs IC, Adler JR, Chang SD. Efficacy and safety of stereotactic radiosurgery for glomus jugulare tumors. Neurosurg Focus 2004; 17:E11.
Liscak R, Urgosik D, Chytka T, et al. Leksell Gamma Knife radiosurgery of the jugulotympanic glomus tumor: Long-term results. J Neurosurg 2014; 121 Suppl:198–202.
Jeyarajan H, Ritchie LM, Obholzer R. Contemporary management of jugular paragangliomas. Otorhinolaryngologist 2017; 10:
Williams MD. Paragangliomas of the head and neck: An overview from diagnosis to genetics. Head Neck Pathol 2017; 11:278–287.
Faustino-Rocha A, Oliveira PA, Pinho-Oliveira J, et al. Estimation of rat mammary tumor volume using caliper and ultrasonography measurements. Lab Anim (NY) 2013; 42:217–224.
Yu YL, Lee MS, Juan CJ, Hueng DY. Calculating the tumor volume of acoustic neuromas: Comparison of ABC/2 formula with planimetry method. Clin Neurol Neurosurg 2013; 115:1371–1374.
Mandrekar SJ, An MW, Meyers J, Grothey A, Bogaerts J, Sargent DJ. Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouse. J Clin Oncol 2014; 32:841–850.
Papaspyrou K, Mewes T, Rossmann H, et al. Head and neck paragangliomas: Report of 175 patients (1989–2010). Head Neck 2012; 34:632–637.
Künzel J, Iro H, Hornung J, et al. Function-preserving therapy for jugulotympanic paragangliomas: A retrospective analysis from 2000 to 2010. Laryngoscope 2012; 122:1545–1551.
Huy PT, Kania R, Duet M, Dessard-Diana B, Mazeron JJ, Benhamed R. Evolving concepts in the management of jugular paraganglioma: A comparison of radiotherapy and surgery in 88 cases. Skull Base 2009; 19:83–91.
Borba LAB, Araújo JC, de Oliveira JG, et al. Surgical management of glomus jugulare tumors: A proposal for approach selection based on tumor relationships with the facial nerve. J Neurosurg 2010; 112:88–98.
Prasad SC, Mimoune HA, Khardaly M, Piazza P, Russo A, Sanna M. Strategies and long-term outcomes in the surgical management of tympanojugular paragangliomas. Head Neck 2016; 38:871–885.
Suarez C, Rodrigo JP, Mendenhall WM, et al. Carotid body paragangliomas: A systematic study on management with surgery and radiotherapy. Eur Arch Otorhinolaryngol 2014; 271:23–34.
Moore MG, Netterville JL, Mendenhall WM, Isaacson B, Nussenbaum B. Head and neck paragangliomas: An update on evaluation and management. Otolaryngol Head Neck Surg 2016; 154:597–605.
Suárez C, Rodrigo JP, Bödeker CC, et al. Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy. Head Neck 2013; 35:1195–1204.
Hinerman RW, Amdur RJ, Morris CG, Kirwan J, Mendenhall WM. Definitive radiotherapy in the management of paragangliomas arising in the head and neck: A 35-year experience. Head Neck 2008; 30:1431–1438.
Sager O, Dincoglan F, Beyzadeoglu M. Stereotactic radiosurgery of glomus jugulare tumors: Current concepts, recent advances and future perspectives. CNS Oncol 2015; 4:105–114.
Jackson CG, McGrew BM, Forest JA, Netterville JL, Hampf CF, Glasscock ME. Lateral skull base surgery for glomus tumors: Long-term control. Otol Neurotol 2001; 22:377–382.
Wanna GB, Sweeney AD, Carlson ML, et al. Subtotal resection for management of large jugular paragangliomas with functional lower cranial nerves. Otolaryngol Head Neck Surg 2014; 151:991–995.
Hafez RFA, Morgan MS, Fahmy OM. An intermediate term benefits and complications of gamma knife surgery in management of glomus jugulare tumor. World J Surg Oncol 2016; 14:36.
Jordan JA, Roland PS, McManus C, Weiner RL, Giller CA. Stereotactic radiosurgery for glomus jugulare tumors. Laryngoscope 2000; 110:35–38.
Guss ZD, Batra S, Limb CJ, et al. Radiosurgery of glomus jugulare tumors: A meta-analysis. Int J Radiat Oncol Biol Phys 2011; 81:e497–502.
Sheehan JP, Tanaka S, Link MJ, et al. Gamma Knife surgery for the management of glomus tumors: A multicenter study. J Neurosurg 2012; 117:246–254.
Lamer JM, Hahn SS, Spaulding CA, Constable WC. Glomus jugulare tumors long-term control by radiation therapy. Cancer 1992; 69:1813–1817.
Ivan ME, Sughrue ME, Clark AJ, et al. A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg 2011; 114:1299–1305.
Hu K, Persky MS. Treatment of head and neck paragangliomas. Cancer Control 2016; 23:228–241.
Pollock BE. Stereotactic radiosurgery in patients with glomus jugulare tumors. Neurosurg Focus 2004; 17:63–67.
Kruger AJ, Walker PJ, Foster WJ, Jenkins JS, Boyne NS, Jenkins J. Important observations made managing carotid body tumors during a 25-year experience. J Vasc Surg 2010; 52:1518–1523.
Lindberg K, Kouti A, Ziegelitz D, Hallén T, Skoglund T, Farahmand D. Three-dimensional volumetric segmentation of pituitary tumors: Assessment of inter-rater agreement and comparison with conventional geometric equations. J Neurol Surg B Skull Base 2018; 79:475–481.
Foote RL, Pollock BE, Gorman DA, et al. Glomus jugulare tumor: Tumor control and complications after stereotactic radiosurgery. Head Neck 2002; 24:332–338. discussion 338–9.

Auteurs

Joshua L Anderson (JL)

Vanderbilt University School of Medicine.

Mohamed H Khattab (MH)

Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.

Chelsea Anderson (C)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina.

Alexander D Sherry (AD)

Vanderbilt University School of Medicine.

Guozhen Luo (G)

Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.

Nauman Manzoor (N)

Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee.

Albert Attia (A)

Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.

James Netterville (J)

Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee.

Anthony J Cmelak (AJ)

Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH